EU consults on simplifying veterinary medicines framework - update
This article was originally published in SRA
The European Commission has launched a public consultation to identify the strengths and weaknesses of the current legal framework for veterinary medicinal products1,2.
You may also be interested in...
The European Directorate for the Quality of Medicines & HealthCare is proceeding carefully to find the right balance between serving the diverse requirements of various stakeholders that make use of its ‘certificates of suitability.’
The International Pharmaceutical Regulators Programme has documented various approaches currently being used for the clinical comparability of biosimilar monoclonal antibodies in different jurisdictions.
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.